# Assessing the Clinical Benefit of Molecular Profiling in Patients With Solid Tumors

> **NCT03061305** · — · TERMINATED · sponsor: **Strata Oncology** · enrollment: 58213 (actual)

## Conditions studied

- Cancer
- Adult Solid Tumor
- Lymphoma
- Multiple Myeloma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03061305
- **Lead sponsor:** Strata Oncology
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2016-11
- **Primary completion:** 2024-06-27
- **Final completion:** 2024-06-27
- **Target enrollment:** 58213 (ACTUAL)
- **Why stopped:** Sponsor's discretion to termination due to business decision.
- **Last updated:** 2025-01-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03061305

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03061305, "Assessing the Clinical Benefit of Molecular Profiling in Patients With Solid Tumors". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03061305. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*